CD28-independent induction of experimental autoimmune encephalomyelitis
Authors:
Open Access
- 1 March 2001
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 107 (5) , 575-583
Abstract
Experimental autoimmune encephalomyelitis (EAE) is a T cell–mediated disease initiated by antigen-specific CD4+ T cells. Signaling through CD28 is a critical second signal for activation of T cells, and CD28 knockout (CD28KO) mice have been reported to be resistant to induction of EAE. We now report that CD28KO mice have no intrinsic defect in mediating disease, because they developed EAE after passive transfer of primed T cells. After immunization, peripheral T cells from CD28KO mice were primed and developed memory phenotype, but had decreased antigen-specific IFN-γ production as compared with cells from wild-type (WT) animals. Reimmunization of CD28KO mice brought out clinical disease and increased IFN-γ production in vitro. Pathologically, there were cellular infiltrates in the central nervous system, in contrast to single-immunized mice. We show furthermore that blocking B7-1 or CTLA4, but not B7-2, in CD28KO mice induces disease after a single immunization. Thus, EAE can be induced in animals lacking CD28-dependent costimulation, suggesting that alternative costimulatory pathways were used. Blocking the OX40-OX40L costimulatory pathway differentially affected disease induction in CD28KO mice as compared with WT controls. Our data show that EAE may develop in the absence of CD28 T-cell costimulation. These findings have implications for therapies aimed at blocking costimulatory signals in autoimmune diseases.Keywords
This publication has 65 references indexed in Scilit:
- OX-40: life beyond the effector T cell stageSeminars in Immunology, 1998
- From Naive to Memory T CellsImmunological Reviews, 1996
- The Roles of Costimulation and Fas in T Cell Apoptosis and Peripheral ToleranceImmunity, 1996
- The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells.Journal of Experimental Medicine, 1996
- The CD28/CTLA-4:B7 receptor system in experimental autoimmune encephalomyelitis.Journal of Clinical Investigation, 1995
- Treatment of Murine Lupus with CTLA4IgScience, 1994
- CTLA-4 can function as a negative regulator of T cell activationImmunity, 1994
- The Role of the CD28 Receptor During T Cell Responses to AntigenAnnual Review of Immunology, 1993
- A Cell Culture Model for T Lymphocyte Clonal AnergyScience, 1990
- Clonal Expansion Versus Functional Clonal Inactivation: A Costimulatory Signalling Pathway Determines the Outcome of T Cell Antigen Receptor OccupancyAnnual Review of Immunology, 1989